These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 6790640)

  • 1. [Chemo-endocrine therapy for advanced breast cancer--a combined treatment with tamoxifen and FT 207-- (author's transl)].
    Wada T; Koyama H; Nishizawa Y; Takahashi Y; Fukuda I; Iwanaga T; Terasawa T
    Nihon Gan Chiryo Gakkai Shi; 1981 Feb; 16(1):51-5. PubMed ID: 6790640
    [No Abstract]   [Full Text] [Related]  

  • 2. [Significance of chemo-endocrine therapy in advanced breast cancer--a combined administration of tamoxifen, tegafur, and cyclophosphamide].
    Wada T; Koyama H; Nishizawa Y; Iwanaga T; Terasawa T
    Nihon Gan Chiryo Gakkai Shi; 1982 Dec; 17(8):2093-100. PubMed ID: 6820378
    [No Abstract]   [Full Text] [Related]  

  • 3. [ACF combination consisting of adriamycin, cyclophosphamide and oral futraful for recurrent advanced breast cancer (author's transl)].
    Murosaki S; Inagaki J; Horikoshi N; Esaki K; Inoue K; Nagura E; Ueoka H; Takano Y; Kobayashi T; Okabe K; Ogawa M
    Nihon Gan Chiryo Gakkai Shi; 1981 Feb; 16(1):8-14. PubMed ID: 6790641
    [No Abstract]   [Full Text] [Related]  

  • 4. Tamoxifen alone versus tamoxifen plus 1-(2-tetrahydrofuryl)-5-fluorouracil in the treatment of advanced breast cancer: a sequential trial.
    Wada T; Koyama H; Terasawa T
    Breast Cancer Res Treat; 1981; 1(1):53-8. PubMed ID: 6816315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preliminary report of adjuvant chemo-endocrine therapy for breast cancer].
    Kitamura M; Tominaga T; Hayashi K; Takahashi I; Kosaki G
    Gan To Kagaku Ryoho; 1985 Jan; 12(1):111-7. PubMed ID: 3917652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive implications of nucleoside metabolizing enzymes in premenopausal women with node-positive primary breast cancer who were randomly assigned to receive tamoxifen alone or tamoxifen plus tegafur-uracil as adjuvant therapy.
    Toi M; Ikeda T; Akiyama F; Kurosumi M; Tsuda H; Sakamoto G; Abe O
    Int J Oncol; 2007 Oct; 31(4):899-906. PubMed ID: 17786323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adjuvant endocrine therapy and chemotherapy of breast cancer (author's transl)].
    Heuson JC; Paridaens R
    Rev Med Brux; 1982 Apr; 3(4):209-16. PubMed ID: 7046007
    [No Abstract]   [Full Text] [Related]  

  • 8. [ACFT therapy using adriamycin, cyclophosphamide, tegafur and tamoxifen against progressive breast cancer].
    Watanabe Y; Tamura M; Meguro F
    Gan To Kagaku Ryoho; 1988 May; 15(5):1711-4. PubMed ID: 3130805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A combined immuno-chemotherapy with futraful and picibanil for advanced cancer (author's transl)].
    Sawai K; Sonoda Y; Ohkuma S; Misawa S; Takino T
    Nihon Gan Chiryo Gakkai Shi; 1977 Sep; 12(3):328-35. PubMed ID: 335004
    [No Abstract]   [Full Text] [Related]  

  • 10. ["State of the art" of adjuvant chemo-endocrine therapy for breast cancer in Japan].
    Ikeda T
    Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():370-6. PubMed ID: 7986117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant setting].
    Inaji H; Sakai K; Oka T; Ozawa K; Saito Y; Senoo T; Taguchi T; Terasawa T; Nakao K; Mori T; Koyama H; Oshima A
    Gan To Kagaku Ryoho; 2006 Oct; 33(10):1423-9. PubMed ID: 17033231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of inoperable esophageal carcinoma responding to adriamycin and FT 207 suppository for more than one year (author's transl)].
    Kabuto T; Taniguchi K; Furukawa H; Iwanaga T; Aoki Y; Terasawa T
    Nihon Gan Chiryo Gakkai Shi; 1981 Jun; 16(3):409-13. PubMed ID: 6798152
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical study of preoperative chemotherapy of primary breast cancer. 1. Efficacy of a combined use of CPA (endoxan) and FT-207 (or 5-FU dry syrup)].
    Komuro K; Hara Y; Fujii Y; Yamazaki M; Amano R; Hashiguchi F; Sakamoto R; Nakamura R; Shimada A; Kurata T; Ando H; Nakamura K
    Gan To Kagaku Ryoho; 1982 Dec; 9(12):2180-5. PubMed ID: 6820892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A combined chemo-endocrine therapy with tegafur, adriamycin, methotrexate and tamoxifen for advanced renal cell carcinoma].
    Wada T; Morikawa E; Yasutomi M; Takagi H; Aizawa M; Abe T; Wada A
    Nihon Gan Chiryo Gakkai Shi; 1990 Aug; 25(8):1652-6. PubMed ID: 2230447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of recurrent breast cancer responding to long-term administration of tamoxifen].
    Yayoi E; Kobayashi T; Inaji H; Maeura Y; Mori T
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1683-6. PubMed ID: 6433801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combination therapy with medroxyprogesterone acetate and tegafur in tamoxifen- and adriamycin-resistant advanced breast cancers].
    Wada T; Matunami N; Houjou T; Morikawa E; Mori N; Nakano K; Aizawa M; Kurooka K; Kadota K; Yamato M
    Gan To Kagaku Ryoho; 1989 May; 16(5):2087-92. PubMed ID: 2525004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cooperative research on post-operative adjuvant therapy of breast cancer. Tohoku Society of Adjuvant Chemo-endocrine Therapy of Breast Cancer].
    Abe R; Tsuchiya A; Koie H; Ono K; Abo S; Saito K; Tsukamoto M; Sato T; Mori S; Motoki R
    Gan To Kagaku Ryoho; 1988 Sep; 15(9):2707-12. PubMed ID: 3137888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tamoxifen plus tegafur plus low-dose adriamycin in the treatment of advanced breast cancer in an outpatient basis].
    Shiba E; Koyama H; Noguchi S; Nishizawa Y; Iwanaga T; Terasawa T
    Nihon Gan Chiryo Gakkai Shi; 1987 Oct; 22(9):2196-201. PubMed ID: 3128615
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effectiveness of ftorafur and hexamethylmelamine in advanced breast cancer].
    Lichinitser MR; Perevodchikova NI; Garin AM; Asserkritova IV; Vaarik GKh
    Vopr Onkol; 1978; 24(8):60-5. PubMed ID: 99870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of chemotherapy of breast cancer (2). Clinical evaluation of the blood and tissue concentrations of FT-207 following intrarectal administration].
    Hiraide H; Mimura K; Kawano M; Hatsuse K; Kadota T; Kurokawa T; Tamaki K; Kanabe S; Mizoguchi O; Terashima H; Iwasa H
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 1):992-6. PubMed ID: 6408994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.